SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,329 | -2.8% | 3,352 | -8.2% | 0.01% | 0.0% |
| Q2 2023 | $418,227 | -16.5% | 3,652 | +0.5% | 0.01% | -28.6% |
| Q1 2023 | $500,736 | +6.4% | 3,633 | 0.0% | 0.01% | +16.7% |
| Q4 2022 | $470,764 | -11.8% | 3,633 | -24.8% | 0.01% | -25.0% |
| Q3 2022 | $534,000 | -50.3% | 4,833 | -66.3% | 0.01% | -46.7% |
| Q2 2022 | $1,074,000 | -15.6% | 14,333 | -12.0% | 0.02% | -6.2% |
| Q1 2022 | $1,272,000 | +396.9% | 16,281 | +985.4% | 0.02% | +300.0% |
| Q4 2020 | $256,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |